Motilal Oswal Private Equity (MOPE) and Rosewood Investments, the private equity arm of The Rosewood Corporation, have bought out private equity major Actis’ 70 per cent holding in Symbiotec Pharmalab Pvt Ltd, according to an announcement on Tuesday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in